Abstract:Topic: 22. Stem cell transplantation - Clinical Background: As a rare but life-threatening critical complication following allogenic haematopoietic stem cell transplantation (allo-HSCT), liver failure is significantly related to poor survival and increased non-relapse mortality. Therefore, identifying patients at high risk of death who should receive specific therapeutic management is key to improving their survival. Here, we established the first clinical prognostic model to predict post-transplant liver failure prognosis to facilitate physician decision-making. Aims: This study was aimed at establishing a prognostic model for selecting post-transplant patients who are at a higher risk of liver failure and disease mortality. Methods: We retrospectively evaluated 113 consecutive liver failure patients who underwent allo-HSCT at a single centre between 2010 and 2022. These patients were further randomly divided into a derivation cohort of 57 patients and a validation cohort of 56 patients. Pearson’s chi-square test and Fisher’s exact test were applied to compare the categorical variables. Outcomes described by the cumulative incidence of overall survival (OS), non-relapse mortality (NRM) and relapse were evaluated by Kaplan-Meier method and the log-rank test. We assessed the prognostic model performance by evaluating the discrimination [area under the curve (AUC)], calibration (calibration plot), and net benefit [decision curve analysis (DCA)]. Results: In total, 113 of 16819 patients (0.67%) were diagnosed with liver failure after transplantation. Disseminated intravascular coagulation (DIC), viral hepatitis, acute kidney injury (AKI), gastrointestinal disease or bleeding, poor platelet implantation, and chronic graft versus host disease (cGHVD) were determined to be significant risk factors for the occurrence of liver failure after allo-HSCT. Because of the higher mortality rate after liver failure, these factors are also significantly related to mortality in patients with liver failure after allo-HSCT. The AUCs of the model were 0.887 (95% CI 0.833-0.940) and 0.770 (0.701-0.839) for the training and validation cohorts, respectively. The calibration plots showed high consistency between the predicted and observed outcomes. Patients were further classified into low-risk and high-risk categories while considering the observed death distribution of the total cohort by tertiles of 2-year outcome probability according to the score. Significant differences in Kaplan-Meier estimations of overall survival were obtained. Summary/Conclusion: The predictive models developed for the occurrence and mortality of liver failure performed well in terms of discrimination, and they might assist clinicians with personalized strategies for liver failure prevention and treatment in patients after allo-HSCT. Keywords: Liver, Allogeneic hematopoietic stem cell transplant, Prognostic factor

Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation.

Risk and Prognostic Factors of Transplantation‐associated Thrombotic Microangiopathy in Allogeneic Haematopoietic Stem Cell Transplantation: a Nested Case Control Study

Race Does Not Predict Pancreas Graft Failure after Pancreas Transplantation in Modern Era

Acute Cholecystitis Following Allogeneic Hematopoietic Stem Cell Transplantation: Clinical Features, Outcomes, Risk Factors, and Prediction Model.

Evaluation the Risk Factor of Transplantation-Associated Thrombotic Microangiopathy.

Risk Stratification System for Skin and Soft Tissue Infections after Allogeneic Hematopoietic Stem Cell Transplantation: PAH Risk Score.

[Exploration of Acute Graft Versus Host Disease and Its Risk Factors after Allo-Hematopoietic Stem Cell Transplantation].

Risk Factors for Acute Graft-Versus-Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience.

Risk factors and predictive model for mortality in patients undergoing allogeneic hematopoietic stem cell transplantation admitted to the intensive care unit

PB2409: CLINICAL PROGNOSTIC MODEL OF LIVER FAILURE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

[Analysis of Risk Factors for the Development of Acute Graft-Versus-host Disease in 151 Cases of Allo-Hematopoietic Stem Cell Transplantation].

Report of Two Cases of Acute Pancreatitis after Liver Transplantation for Hcc

[Clinical Analysis of Acute Renal Failure after Allogeneic Hematopoietic Stem Cell Transplantation].

A Risk Score for Mortality after Allogeneic Hematopoietic Cell Transplantation

Abstract 13185: Incidence and Risk Factors of Acute Cardiovascular Complications After Hematopoietic Stem Cell Transplantation

A new multi-factor risk score system for predicting the outcome after allogenic hematopoietic stem cell transplantation]

Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Overt Gastrointestinal Bleeding Following Haploidentical Haematopoietic Stem Cell Transplantation: Incidence, Outcomes and Predictive Models

Impact of pretransplantation risk factors on post transplantation outcome of patients with acute myeloid leukemia in remission after haploidentical hematopoietic stem cell transplantation.

[The Risk Factors of Post-Transplant Lymphoproliferative Disorders Following Haploidentical Hematopoietic Stem Cell Transplantation].

Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation